AKORN, INC. AND GENERAMEDIX SIGN COMMERCIAL MANUFACTURING SUPPLY AGREEMENT

Akorn, Inc. announced that it has signed a Commercial Manufacturing Supply Agreement with GeneraMedix Inc., a privately held pharmaceutical company that develops, markets and sells generic injectable pharmaceutical products. Under the terms of the Agreement, Akorn will manufacture injectable products in finished dosage form for GeneraMedix, who will market these products in the GeneraMedix label. The Agreement includes products currently available from Akorn, as well as select injectable products from the Akorn internal product development pipeline.
BioSpace